aldric-hama
- Jan 12

HPR participating in ISC2023

Dallas, TX * February 8-10, 2023

Recent Posts

Regenerative effects of PRP injection is published in Arthritis Research & Therapy.

We hereby announce that Hamamatsu Pharma Research, Inc. has joined as a subsidiary company of CMIC HOLDINGS Co., Ltd. Notice Concerning the Acquisition of Hamamatsu Pharma Research, Inc. as a Subsidia

HPR Participating in Society for Neuroscience 2023